Literature DB >> 1875168

Differentiation of primitive human multipotent hematopoietic progenitors into single lineage clonogenic progenitors is accompanied by alterations in their interaction with fibronectin.

C M Verfaillie1, J B McCarthy, P B McGlave.   

Abstract

We have previously demonstrated that primitive progenitors from human bone marrow termed long term bone marrow culture initiating cells (LTBMC-IC) adhere avidly to irradiated bone marrow stroma, while more mature clonogenic progenitors fail to do so. In this study we examine the interaction between these progenitors and components of the bone marrow stroma. (a) We demonstrate that both primitive LTBMC-IC and more mature clonogenic progenitors adhere to intact fibronectin. (b) Primitive LTBMC-IC and multi-lineage CFU-MIX progenitors adhere to the 33/66 kD COOH-terminal heparin-binding cell-adhesion promoting fragment of fibronectin, but adhere significantly less to its 75 kD RGDS-dependent cell-binding fragment. In contrast, more differentiated single-lineage progenitors adhere equally well to the 33/66 kD RGDS independent and the 75 kD RGDS-dependent cell-adhesion fragments of fibronectin. (c) Both primitive LTBMC-IC and clonogenic progenitors adhere to the three known cell-attachment sites in the 33/66 kD cell-adhesion promoting fragment, FN-C/H I, FN-C/H II and CS1. However, LTBMC-IC and CFU-MIX progenitors adhere significantly better to FN-C/H II than to the flanking FN-C/H I and CS1 cell-attachment sites. In contrast, single-lineage progenitors adhere equally well to all three cell attachment sites in the 33/66 kD cell-adhesion promoting fragment. (d) Finally, adhesion of primitive LTBMC-IC to intact irradiated stroma can be inhibited partially by peptide FN-C/H II and almost completely by a combination of FN-C/H II and peptide FN-C/H I and CS1. This study demonstrates that adhesive interactions between primitive hematopoietic progenitors and the extracellular matrix component fibronectin can occur. Specific changes in adhesion to the 33/66 kD cell-adhesion promoting fragment and the 75 kD RGDS-dependent cell-adhesion fragment of fibronectin are associated with differentiation of primitive multi-lineage progenitors into committed single-lineage progenitors. Such differences in adhesive interaction with fibronectin may allow hematopoietic progenitors at various stages of differentiation to interact with specific supportive loci of the bone marrow microenvironment. Finally, the ability to block adhesion of LTBMC-IC to intact irradiated stroma with peptides FN-C/H II, FN-C/H I and CS1 suggests that receptors responsible for this interaction may be important in the homing of primitive progenitors to the bone marrow.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1875168      PMCID: PMC2118931          DOI: 10.1084/jem.174.3.693

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  45 in total

1.  Lineage- and stage-specific adhesion of human hematopoietic progenitor cells to extracellular matrices from marrow fibroblasts.

Authors:  L Coulombel; M H Vuillet; C Leroy; G Tchernia
Journal:  Blood       Date:  1988-02       Impact factor: 22.113

2.  Dual role of fibronectin in hematopoietic differentiation.

Authors:  R Weinstein; M A Riordan; K Wenc; S Kreczko; M Zhou; N Dainiak
Journal:  Blood       Date:  1989-01       Impact factor: 22.113

3.  In vitro homing of hemopoietic stem cells is mediated by a recognition system with galactosyl and mannosyl specificities.

Authors:  S Aizawa; M Tavassoli
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

4.  Differential binding of erythroid and myeloid progenitors to fibroblasts and fibronectin.

Authors:  S Tsai; V Patel; E Beaumont; H F Lodish; D G Nathan; C A Sieff
Journal:  Blood       Date:  1987-06       Impact factor: 22.113

5.  Identification of two distinct regions of the type III connecting segment of human plasma fibronectin that promote cell type-specific adhesion.

Authors:  M J Humphries; A Komoriya; S K Akiyama; K Olden; K M Yamada
Journal:  J Biol Chem       Date:  1987-05-15       Impact factor: 5.157

6.  Haemonectin, a bone marrow adhesion protein specific for cells of granulocyte lineage.

Authors:  A D Campbell; M W Long; M S Wicha
Journal:  Nature       Date:  1987 Oct 22-28       Impact factor: 49.962

7.  Extracellular matrix promotes the growth and differentiation of murine hematopoietic cells in vitro.

Authors:  A Campbell; M S Wicha; M Long
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

8.  Successful autografting in chronic myeloid leukaemia after maintenance of marrow in culture.

Authors:  M J Barnett; C J Eaves; G L Phillips; D K Kalousek; H G Klingemann; P M Lansdorp; D E Reece; J D Shepherd; G J Shaw; A C Eaves
Journal:  Bone Marrow Transplant       Date:  1989-07       Impact factor: 5.483

9.  Homing of hemopoietic precursor cells to the embryonic thymus: characterization of an invasive mechanism induced by chemotactic peptides.

Authors:  P Savagner; B A Imhof; K M Yamada; J P Thiery
Journal:  J Cell Biol       Date:  1986-12       Impact factor: 10.539

10.  Human fibronectin contains distinct adhesion- and motility-promoting domains for metastatic melanoma cells.

Authors:  J B McCarthy; S T Hagen; L T Furcht
Journal:  J Cell Biol       Date:  1986-01       Impact factor: 10.539

View more
  34 in total

1.  Rac and Cdc42 GTPases control hematopoietic stem cell shape, adhesion, migration, and mobilization.

Authors:  F C Yang; S J Atkinson; Y Gu; J B Borneo; A W Roberts; Y Zheng; J Pennington; D A Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

Review 2.  Regulatory pathways in blood-forming tissue with particular reference to gap junctional communication.

Authors:  M Rosendaal ; T Krenács T
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

3.  Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV.

Authors:  C M Verfaillie; J B McCarthy; P B McGlave
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

4.  Surface-immobilization of adhesion peptides on substrate for ex vivo expansion of cryopreserved umbilical cord blood CD34+ cells.

Authors:  Xue-Song Jiang; Chou Chai; Yue Zhang; Ren-Xi Zhuo; Hai-Quan Mao; Kam W Leong
Journal:  Biomaterials       Date:  2006-01-10       Impact factor: 12.479

5.  Interferon-alpha restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired beta 1 integrin receptor function.

Authors:  R Bhatia; E A Wayner; P B McGlave; C M Verfaillie
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

Review 6.  Molecular characterization of CD34+ human hematopoietic progenitor cells.

Authors:  W Knapp; H Strobl; C Scheinecker; C Bello-Fernandez; O Majdic
Journal:  Ann Hematol       Date:  1995-06       Impact factor: 3.673

7.  Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin.

Authors:  T Papayannopoulou; B Nakamoto
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

8.  VLA-5 is expressed by mouse and human long-term repopulating hematopoietic cells and mediates adhesion to extracellular matrix protein fibronectin.

Authors:  J C van der Loo; X Xiao; D McMillin; K Hashino; I Kato; D A Williams
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

9.  Treatment of marrow stroma with interferon-alpha restores normal beta 1 integrin-dependent adhesion of chronic myelogenous leukemia hematopoietic progenitors. Role of MIP-1 alpha.

Authors:  R Bhatia; P B McGlave; C M Verfaillie
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

10.  Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation.

Authors:  R W Hurley; J B McCarthy; C M Verfaillie
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.